• Benign Prostatic Hyperplasia
  • Hormone Therapy
  • Genomic Testing
  • Next-Generation Imaging
  • UTUC
  • OAB and Incontinence
  • Genitourinary Cancers
  • Kidney Cancer
  • Men's Health
  • Pediatrics
  • Female Urology
  • Sexual Dysfunction
  • Kidney Stones
  • Urologic Surgery
  • Bladder Cancer
  • Benign Conditions
  • Prostate Cancer

Latest News

First commercial doses of N-803 for NMIBC administered across US
First commercial doses of N-803 for NMIBC administered across US

June 20th 2024

N-803 was approved by the FDA in April 2024 for the treatment of patients with BCG-unresponsive NMIBC carcinoma in situ with or without papillary tumors.

Phase 2 study launches of bremelanotide plus a PDE5 inhibitor for erectile dysfunction
Phase 2 study launches of bremelanotide plus a PDE5 inhibitor for erectile dysfunction

June 20th 2024

Urinary genomic test demonstrates utility in cystoscopy decision-making
Urinary genomic test demonstrates utility in cystoscopy decision-making

June 19th 2024

Closeup financial chart | Image Credit: © iamchamp - stock.adobe.com
Money Matters: Smart investing when markets approach record highs

June 19th 2024

D-mannose found to be ineffective for prevention of recurrent UTI
D-mannose found to be ineffective for prevention of recurrent UTI

June 19th 2024

Latest Videos

Latest News

© 2024 MJH Life Sciences

All rights reserved.